These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 21495232)

  • 1. Evaluation of tumor-free distance and depth of myometrial invasion as prognostic factors for lymph node metastases in endometrial cancer.
    Kondalsamy-Chennakesavan S; van Vugt S; Sanday K; Nicklin J; Land R; Perrin L; Crandon A; Obermair A
    Int J Gynecol Cancer; 2010 Oct; 20(7):1217-21. PubMed ID: 21495232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective evaluation of prognostic significance of the tumor-free distance from uterine serosa in surgically staged endometrial adenocarcinoma.
    Schwab KV; O'Malley DM; Fowler JM; Copeland LJ; Cohn DE
    Gynecol Oncol; 2009 Jan; 112(1):146-9. PubMed ID: 18937970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour-free distance from serosa is a better prognostic indicator than depth of invasion and percentage myometrial invasion in endometrioid endometrial cancer.
    Chattopadhyay S; Galaal KA; Patel A; Fisher A; Nayar A; Cross P; Naik R
    BJOG; 2012 Sep; 119(10):1162-70. PubMed ID: 22804815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a prognostic difference between depth of myometrial invasion and the tumor-free distance from the uterine serosa in endometrial cancer?
    Lindauer J; Fowler JM; Manolitsas TP; Copeland LJ; Eaton LA; Ramirez NC; Cohn DE
    Gynecol Oncol; 2003 Dec; 91(3):547-51. PubMed ID: 14675674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of myometrial invasion and tumor free distance from uterine serosa in endometrial cancer.
    Ozbilen O; Sakarya DK; Bezircioglu I; Kasap B; Yetimalar H; Yigit S
    Asian Pac J Cancer Prev; 2015; 16(2):519-22. PubMed ID: 25684481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absolute depth of myometrial invasion in endometrial cancer is superior to the currently used cut-off value of 50%.
    Geels YP; Pijnenborg JM; van den Berg-van Erp SH; Snijders MP; Bulten J; Massuger LF
    Gynecol Oncol; 2013 May; 129(2):285-91. PubMed ID: 23422503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of tumor-free distance and depth of myometrial invasion as prognostic factors in endometrial cancer.
    Doghri R; Chaabouni S; Houcine Y; Charfi L; Boujelbene N; Driss M; Mrad K
    Mol Clin Oncol; 2018 Jul; 9(1):87-91. PubMed ID: 29896403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproducibility of measurement of myometrial invasion in endometrial carcinoma.
    van der Putten LJ; van de Vijver K; Bartosch C; Davidson B; Gatius S; Matias-Guiu X; McCluggage WG; Toledo G; van der Wurff AA; Pijnenborg JM; Massuger LF; Bulten J
    Virchows Arch; 2017 Jan; 470(1):63-68. PubMed ID: 27787595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nomogram to Predict Risk of Lymph Node Metastases in Patients With Endometrioid Endometrial Cancer.
    Pollom EL; Conklin CM; von Eyben R; Folkins AK; Kidd EA
    Int J Gynecol Pathol; 2016 Sep; 35(5):395-401. PubMed ID: 26598977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph Node Metastasis in Patients With Endometrioid Endometrial Cancer: Overtreatment Is the Main Issue.
    Karalok A; Turan T; Basaran D; Turkmen O; Comert Kimyon G; Tulunay G; Tasci T
    Int J Gynecol Cancer; 2017 May; 27(4):748-753. PubMed ID: 28301338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reassessment of myometrial invasion in endometrial carcinoma.
    Kaku T; Tsuruchi N; Tsukamoto N; Hirakawa T; Kamura T; Nakano H
    Obstet Gynecol; 1994 Dec; 84(6):979-82. PubMed ID: 7970481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A modern assessment of the surgical pathologic spread and nodal dissemination of endometrial cancer.
    Praiss AM; Huang Y; St Clair CM; Tergas AI; Melamed A; Khoury-Collado F; Hou JY; Hur C; Ananth CV; Neugut AI; Hershman DL; Wright JD
    Gynecol Oncol; 2020 May; 157(2):329-334. PubMed ID: 32094021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of the microcystic, elongated and fragmented (MELF) invasion pattern in endometrial carcinomas with deep myometrial invasion, lymphovascular space invasion and lymph node metastasis.
    Dogan Altunpulluk M; Kir G; Topal CS; Cetiner H; Gocmen A
    J Obstet Gynaecol; 2015 May; 35(4):397-402. PubMed ID: 25279582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pattern of myometrial invasion as a predictor of lymph node metastasis or extrauterine disease in low-grade endometrial carcinoma.
    Euscher E; Fox P; Bassett R; Al-Ghawi H; Ali-Fehmi R; Barbuto D; Djordjevic B; Frauenhoffer E; Kim I; Hong SR; Montiel D; Moschiano E; Roma A; Silva E; Malpica A
    Am J Surg Pathol; 2013 Nov; 37(11):1728-36. PubMed ID: 24061515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial endometrioid adenocarcinoma: a pathologic analysis of 827 consecutive cases.
    Nofech-Mozes S; Ghorab Z; Ismiil N; Ackerman I; Thomas G; Barbera L; Covens A; Khalifa MA
    Am J Clin Pathol; 2008 Jan; 129(1):110-4. PubMed ID: 18089496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative MRI and intraoperative frozen section diagnosis of myometrial invasion in patients with endometrial cancer.
    Tanaka T; Terai Y; Ono YJ; Fujiwara S; Tanaka Y; Sasaki H; Tsunetoh S; Kanemura M; Yamamoto K; Yamada T; Ohmichi M
    Int J Gynecol Cancer; 2015 Jun; 25(5):879-83. PubMed ID: 25950131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk of lymph node metastasis based on myometrial invasion and tumor grade in endometrioid uterine cancers: a multicenter, retrospective Korean study.
    Lee KB; Ki KD; Lee JM; Lee JK; Kim JW; Cho CH; Kim SM; Park SY; Jeong DH; Kim KT
    Ann Surg Oncol; 2009 Oct; 16(10):2882-7. PubMed ID: 19484311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: a SEER analysis.
    Vargas R; Rauh-Hain JA; Clemmer J; Clark RM; Goodman A; Growdon WB; Schorge JO; Del Carmen MG; Horowitz NS; Boruta DM
    Gynecol Oncol; 2014 May; 133(2):216-20. PubMed ID: 24548726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical invasion, lymphovascular space invasion, and ovarian metastasis as predictors of lymph node metastasis and poor outcome on stages I to III endometrial cancers: a single-center retrospective study.
    Li M; Wu S; Xie Y; Zhang X; Wang Z; Zhu Y; Yan S
    World J Surg Oncol; 2019 Nov; 17(1):193. PubMed ID: 31733657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymph node metastasis in endometrioid adenocarcinomas of the uterine corpus with occult cervical involvement.
    Boren T; Lea J; Kehoe S; Miller DS; Richardson D
    Gynecol Oncol; 2012 Oct; 127(1):43-6. PubMed ID: 22713294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.